DK1399482T3 - Bestemmelse af bone-sialoprotein i kropsvæsker til on-kologiske problemstillinger - Google Patents
Bestemmelse af bone-sialoprotein i kropsvæsker til on-kologiske problemstillingerInfo
- Publication number
- DK1399482T3 DK1399482T3 DK02758218T DK02758218T DK1399482T3 DK 1399482 T3 DK1399482 T3 DK 1399482T3 DK 02758218 T DK02758218 T DK 02758218T DK 02758218 T DK02758218 T DK 02758218T DK 1399482 T3 DK1399482 T3 DK 1399482T3
- Authority
- DK
- Denmark
- Prior art keywords
- bone sialoprotein
- antibodies
- oncological
- issues
- determination
- Prior art date
Links
- 102000016921 Integrin-Binding Sialoprotein Human genes 0.000 title abstract 5
- 108010028750 Integrin-Binding Sialoprotein Proteins 0.000 title abstract 5
- 210000001124 body fluid Anatomy 0.000 title 1
- 239000010839 body fluid Substances 0.000 title 1
- 230000000771 oncological effect Effects 0.000 title 1
- 150000001413 amino acids Chemical class 0.000 abstract 2
- 238000003745 diagnosis Methods 0.000 abstract 2
- 238000004393 prognosis Methods 0.000 abstract 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 abstract 1
- 206010006187 Breast cancer Diseases 0.000 abstract 1
- 208000026310 Breast neoplasm Diseases 0.000 abstract 1
- 206010027452 Metastases to bone Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 210000000988 bone and bone Anatomy 0.000 abstract 1
- 201000008275 breast carcinoma Diseases 0.000 abstract 1
- 230000013595 glycosylation Effects 0.000 abstract 1
- 238000003018 immunoassay Methods 0.000 abstract 1
- 210000004881 tumor cell Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
- C07K2317/11—Immunoglobulins specific features characterized by their source of isolation or production isolated from eggs
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Materials For Medical Uses (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Ceramic Products (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01114388 | 2001-06-13 | ||
| PCT/EP2002/006219 WO2002100901A2 (fr) | 2001-06-13 | 2002-06-06 | Dosage de la sialoproteine osseuse dans des liquides biologiques en matiere d'oncologie |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1399482T3 true DK1399482T3 (da) | 2009-07-20 |
Family
ID=8177717
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK02758218T DK1399482T3 (da) | 2001-06-13 | 2002-06-06 | Bestemmelse af bone-sialoprotein i kropsvæsker til on-kologiske problemstillinger |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US7790853B2 (fr) |
| EP (1) | EP1399482B1 (fr) |
| JP (1) | JP4438987B2 (fr) |
| AT (1) | ATE425991T1 (fr) |
| DE (1) | DE50213368D1 (fr) |
| DK (1) | DK1399482T3 (fr) |
| WO (1) | WO2002100901A2 (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8282943B2 (en) | 2005-05-31 | 2012-10-09 | Ralf Jochem | Therapeutic composition for use in the prevention and treatment of bone metastases |
| JP6675383B2 (ja) * | 2014-08-19 | 2020-04-01 | イムーンダイアグノスティック・アー・ゲー | 慢性腎疾患の治療のための医薬および装置 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5340934A (en) * | 1989-11-03 | 1994-08-23 | The United States Of Americas As Represented By The Secretary Of Health & Human Services | CDNA sequences of human bone matrix proteins |
| CA2103059C (fr) * | 1991-06-14 | 2005-03-22 | Paul J. Carter | Methode de production d'anticorps humanises |
| AU3035699A (en) | 1998-03-27 | 1999-10-18 | Seibel, Markus | Determination of the probability of bone metastases in patients with primary carcinomas |
| AU769773B2 (en) * | 1998-12-22 | 2004-02-05 | University Of Virginia Patent Foundation | Bone sialoprotein based toxic gene therapy for the treatment of calcified tumors and tissues |
| ATE315229T1 (de) | 1999-04-09 | 2006-02-15 | Us Gov Health & Human Serv | Komplex aus n-glykolisierten proteinen (siblings) und faktor h |
-
2002
- 2002-06-06 DK DK02758218T patent/DK1399482T3/da active
- 2002-06-06 JP JP2003503667A patent/JP4438987B2/ja not_active Expired - Lifetime
- 2002-06-06 WO PCT/EP2002/006219 patent/WO2002100901A2/fr active Application Filing
- 2002-06-06 EP EP02758218A patent/EP1399482B1/fr not_active Expired - Lifetime
- 2002-06-06 US US10/480,441 patent/US7790853B2/en not_active Expired - Fee Related
- 2002-06-06 DE DE50213368T patent/DE50213368D1/de not_active Expired - Lifetime
- 2002-06-06 AT AT02758218T patent/ATE425991T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| US7790853B2 (en) | 2010-09-07 |
| ATE425991T1 (de) | 2009-04-15 |
| DE50213368D1 (de) | 2009-04-30 |
| US20050054016A1 (en) | 2005-03-10 |
| JP4438987B2 (ja) | 2010-03-24 |
| WO2002100901A2 (fr) | 2002-12-19 |
| WO2002100901A3 (fr) | 2003-09-18 |
| JP2005508870A (ja) | 2005-04-07 |
| EP1399482B1 (fr) | 2009-03-18 |
| EP1399482A2 (fr) | 2004-03-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69433663D1 (de) | Antikörper gegen menschliches prostatspezifisches drüsenkallikrein | |
| BR0213565A (pt) | Anticorpo de anti-tnf alfa modificado | |
| ATE454447T1 (de) | Peptidagonisten für prostata-spezifisches antigen und ihre verwendung | |
| CY1118443T1 (el) | Anti-tnf αντισωματα, συνθεσεις, μεθοδοι και χρησεις | |
| DK1368060T3 (da) | HMGB1-proteininhibitorer og/eller antagonister til behandlingen af vaskulære sygdomme | |
| TR200200472T2 (tr) | Anti-Erb B2 antikorları ile tedavi için dozajlar | |
| BR0208603A (pt) | Marcadores de tumor para carcinoma de células renais | |
| ATE517922T1 (de) | Stabilisierte einzel-domänen-antikörper in einer pharmazeutischen zusammensetzung ausgestaltet für inhalation | |
| AT500379B8 (de) | Tau-proteine | |
| DK1565489T3 (da) | Internaliserende antistoffer specifikke for RAAG10-celleoverflademålet | |
| IL195338A (en) | An antibody comprising an FC variant containing amino acid replaces d or e at position 239, a medicament containing it and its use | |
| BRPI0418766A (pt) | anticorpos e moléculas derivadas destes que se ligam às proteìnas steap-1 | |
| EP2022800A3 (fr) | Compositions utilisés dans la thérapie et le diagnostic du cancer des ovaires | |
| BR0306715A (pt) | Métodos para diagnóstico e tratamento de tumores | |
| TR200001646T2 (tr) | Bir salgılanmış meme kanseri proteini olan mamaglobin. | |
| WO2001068708A3 (fr) | ANTICORPS HUMAINS SPECIFIQUES DE FAP-$g(a) | |
| ATE473279T1 (de) | In metastatischen menschlichen tumorzellen exprimiertes glycoproteinantigen sima135 | |
| BR0212740B1 (pt) | material pulverizado e material cerÂmico fabricado a partir do mesmo. | |
| DK1399482T3 (da) | Bestemmelse af bone-sialoprotein i kropsvæsker til on-kologiske problemstillinger | |
| TR200102655T2 (tr) | Dört L. infantum proteininin antijen belirleyicilerini kodlayan kimerik gen. | |
| DE60113968D1 (de) | Diagnose von brustkrebs unter verwendung von bcmp-7 als marker | |
| ATE290881T1 (de) | Verwendung von anti-ferritin antikörper bei der behandlung von bestimmten krebsarten | |
| CY1109904T1 (el) | Προαγωγεας της il-18bp, η παρασκευη και χρηση του | |
| SG156619A1 (en) | Novel cancer associated antibodies and antigens and their use in cancer diagnosis | |
| EA200600956A1 (ru) | Молекулы-антагонисты цитокинов |